ArticleJTO clinical and research reports2022

Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189.

Shirish Gadgeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.